HistoSonics Announces USD 250mn Financing Growth
HistoSonics, Inc., one of the developers of the Edison Histotripsy System and novel histotripsy therapy platform, recently announced the closing of an oversubscribed USD 250 million financing led by its new ownership group and included additional investors Thiel Bio and Founders Fund, among others. The financing will support the ongoing commercial expansion of HistoSonics’ Edison […]
